Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Prothena Corp Stock (NASDAQ:PRTA), Quotes and News Summary
Prothena Corp Stock (NASDAQ: PRTA) stock price, news, charts, stock research, profile.
| Day Range- - - | 52 Wk Range21.060 - 66.470 | Open / Close- / - | Float / Outstanding22.487M / 51.627M |
| Vol / Avg.0 / 569.882K | Mkt Cap2.868B | P/E- | 50d Avg. Price57.490 |
| Div / Yield (Forward)- / -% | Payout Ratio- | Total Float22.487M | EPS-3.430 |
Earnings
see more| Q4 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.410 | (EXPECTED) 2023-02-16 | |||||
| REV | 31.570M | ||||||
| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.530 | -0.970 | -0.4400 | ||||
| REV | 22.060M | 1.517M | -20.543M |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
How do I buy Prothena Corp (PRTA) stock?
You can purchase shares of Prothena Corp (NASDAQ: PRTA) through any online brokerage.
Who are Prothena Corp's (PRTA) competitors?
Other companies in Prothena Corp’s space includes: Immunovant (NASDAQ:IMVT), Ultragenyx Pharmaceutical (NASDAQ:RARE), Sage Therapeutics (NASDAQ:SAGE), FibroGen (NASDAQ:FGEN) and Xencor (NASDAQ:XNCR).
What is the target price for Prothena Corp (PRTA) stock?
The latest price target for Prothena Corp (NASDAQ: PRTA) was reported by Piper Sandler on Friday, January 27, 2023. The analyst firm set a price target for 94.00 expecting PRTA to rise to within 12 months (a possible 69.22% upside). 9 analyst firms have reported ratings in the last year.
Current Stock Price for Prothena Corp (PRTA)?
The stock price for Prothena Corp (NASDAQ: PRTA) is $55.55 last updated February 2, 2023 at 9:00 PM UTC.
Does Prothena Corp (PRTA) pay a dividend?
There are no upcoming dividends for Prothena Corp.
When is Prothena Corp (NASDAQ:PRTA) reporting earnings?
Prothena Corp’s Q4 earnings are confirmed for Thursday, February 16, 2023.
Is Prothena Corp (PRTA) going to split?
There is no upcoming split for Prothena Corp.
What sector and industry does Prothena Corp (PRTA) operate in?
Prothena Corp is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.